Table 1 Baseline characteristics of the patients

From: Anti- and pro-fibrillatory effects of pulmonary vein isolation gaps in human atrial fibrillation digital twins

Characteristics

 

Male, n (%, n)

72.0% (36/50)

Age (Years)

61.3 ± 9.4

<65, n (%, n)

58.0% (29/50)

65–74, n (%, n)

34.0% (17/50)

≥75, n (%, n)

8% (4/50)

Persistent AF, n (%, n)

76.0% (38/50)

Duration of AF (Months)

29.4 ± 32.3

BMI (kg/m2)

24.4 ± 4.2

CHA2DS2-VASc score

2.1 ± 1.5

Heart failure, n (%, n)

28.0% (14/50)

Hypertension, n (%, n)

48.0% (24/50)

Diabetes, n (%, n)

16.0% (8/50)

Stroke/TIA, n (%, n)

22.0% (11/50)

Echocardiographic parameters

LA dimension (mm)

44.0 ± 5.32

LA volume index (mL/m2)

43.9 ± 12.4

LVEF (%)

61.5 ± 7.7

E/Em

10.4 ± 3.5

Mean LA voltage (mV)

2.0 ± 0.7

Extra-PV trigger (%)

6% (3/50)

  1. Values are presented as the means ± standard deviations or numbers (percentages).
  2. AF atrial fibrillation, BMI body mass index, E early diastolic trans-mitral flow velocity, Em early diastolic mitral annular velocity, LA left atrial, LVEF Left ventricular ejection fraction, TIA transient ischemic attack, PV pulmonary vein.
Back to article page